These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


444 related items for PubMed ID: 15633203

  • 1. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Kim JH, Lee SY, Kim HB, Kim BS, Shim JY, Hong TJ, Hong SJ.
    Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
    [Abstract] [Full Text] [Related]

  • 2. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [Abstract] [Full Text] [Related]

  • 3. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
    Rundell KW, Spiering BA, Baumann JM, Evans TM.
    Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR, La Grutta S, Cibella F, Scichilone N, Cuttitta G, Interrante A, Marchese M, Veca M, Virzi' M, Bonanno A, Profita M, Morici G.
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [Abstract] [Full Text] [Related]

  • 6. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
    Philip G, Villarán C, Pearlman DS, Loeys T, Dass SB, Reiss TF.
    J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
    Sun TY, Guo YF, Xu XM, Zhang HS, Hou J, Ke HX, Li YM, Fang BM, Ming SH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
    [Abstract] [Full Text] [Related]

  • 11. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
    Anderson SD, Brannan JD, Perry CP, Caillaud C, Seale JP.
    J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
    [Abstract] [Full Text] [Related]

  • 12. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children.
    de Benedictis FM, del Giudice MM, Forenza N, Decimo F, de Benedictis D, Capristo A.
    Eur Respir J; 2006 Aug; 28(2):291-5. PubMed ID: 16641126
    [Abstract] [Full Text] [Related]

  • 13. Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction.
    Kang MJ, Lee SY, Kim HB, Yu J, Kim BJ, Choi WA, Jang SO, Hong SJ.
    Pharmacogenet Genomics; 2008 Jul; 18(7):551-8. PubMed ID: 18551035
    [Abstract] [Full Text] [Related]

  • 14. Baseline predictors of placebo response in exercise-induced bronchoconstriction (EIB): pooled regression analysis >from three studies of montelukast in EIB.
    Philip G, Swern AS, Smugar SS, Pearlman DS.
    J Asthma; 2010 Oct; 47(8):935-41. PubMed ID: 20858150
    [Abstract] [Full Text] [Related]

  • 15. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, Loeys T, Dass SB, Reiss TF.
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [Abstract] [Full Text] [Related]

  • 16. Time-effect of montelukast on protection against exercise-induced bronchoconstriction.
    Peroni DG, Pescollderungg L, Sandri M, Chinellato I, Boner AL, Piacentini GL.
    Respir Med; 2011 Dec; 105(12):1790-7. PubMed ID: 21865022
    [Abstract] [Full Text] [Related]

  • 17. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF.
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [Abstract] [Full Text] [Related]

  • 18. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.
    Vidal C, Fernández-Ovide E, Piñeiro J, Nuñez R, González-Quintela A.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):655-8. PubMed ID: 11428738
    [Abstract] [Full Text] [Related]

  • 19. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
    Carraro S, Corradi M, Zanconato S, Alinovi R, Pasquale MF, Zacchello F, Baraldi E.
    J Allergy Clin Immunol; 2005 Apr; 115(4):764-70. PubMed ID: 15805996
    [Abstract] [Full Text] [Related]

  • 20. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.